ScholarLens Back to search
2014•Xiandai shengwu yixue jinzhanRequires access

The Clinical Effect Observation of Chemotherapy Combined with DC and CIK for the Treatment of Non-small Cell Lung Cancer

Yingji Chen

Open publisher page 0 citations

Abstract

Objective: To discuss the clinical effect of chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer. Methods: From October, 2008 to February 2011, 120 patients with non-small cell lung cancer were randomly divided into treatment group(chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) group, n=60)and control group(conventional chemotherapy group, n=60). We summarized the curative effect and the quality of life of patients and made a statistical analysis for the results. Results: In the treatment group, the total effective rate was 68.4%, the improvement rate of the quality of life was 88.4%. It was significantly better when compared with the control group. After the statistical analysis, P0.05, there were significant differences. There was a significant difference in statistics. Conclusion: Chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer can improve the quality of life for the patient. It is a effective method for the treatment of non-small cell lung cancer.

About this research paper

What this paper is about

Objective: To discuss the clinical effect of chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer. Methods: From October, 2008 to February 2011, 120 patients with non-small cell lung cancer were randomly divided into treatment group(chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) group, n=60)and control group(conventional chemotherapy group, n=60). We summarized the curative effect and the quality of life of patients and made a statistical analysis for the results. Results: In the treatment group, the total effective rate was 68.4%, the improvement rate of the quality of life was 88.4%. It was significantly better when compared with the control group. After the statistical analysis, P0.05, there were significant differences. There was a significant difference in statistics. Conclusion: Chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer can improve the quality of life for the patient. It is a effective method for the treatment of non-small cell lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To discuss the clinical effect of chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer. Methods: From October, 2008 to February 2011, 120 patients with non-small cell lung cancer were randomly divided into treatment group(chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) group, n=60)and control group(conventional chemotherapy group, n=60). We summarized the curative effect and the quality of life of patients and made a statistical analysis for the results. Results: In the treatment group, the total effective rate was 68.4%, the improvement rate of the quality of life was 88.4%. It was significantly better when compared with the control group. After the statistical analysis, P0.05, there were significant differences. There was a significant difference in statistics. Conclusion: Chemotherapy combined with dendritic cells(DC) and cytokine-induced killer cells(CIK) for the treatment of non-small cell lung cancer can improve the quality of life for the patient. It is a effective method for the treatment of non-small cell lung cancer.

Key concepts: Cytokine-induced killer cell, Chemotherapy, Lung cancer, Medicine, Dendritic cell, Cytokine, Cancer, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The Clinical Effect Observation of Chemotherapy Combined with DC and CIK for the Treatment of Non-small Cell Lung Cancer — Research Paper | ScholarLens